Related Experiment Video
Updated: Jul 1, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Alendronate for fracture prevention in postmenopause
Kathryn K Holder1, Sara Shelton Kerley
1David Grant Medical Center, Family Medicine Residency Program, Travis AFB, California, USA. kathryn.holder-02@travis.af.mil
Alendronate significantly reduces fracture risk in postmenopausal women, particularly for secondary prevention of vertebral, hip, and wrist fractures. While effective for vertebral fracture prevention in primary cases, overall primary prevention benefits were less pronounced.
Area of Science:
- Osteoporosis Research
- Pharmacological Interventions
- Geriatric Medicine
Background:
- Osteoporosis is characterized by reduced bone mass and deterioration, increasing fracture risk.
- Alendronate, a bisphosphonate, inhibits osteoclast activity to reduce bone resorption.
Purpose of the Study:
- To evaluate the efficacy of alendronate in preventing osteoporotic fractures in postmenopausal women.
- Assessed both primary and secondary prevention strategies.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs) from 1966-2007.
- Included 11 trials with 12,068 participants; data abstraction and analysis were performed in duplicate.
- Assessed study quality based on allocation concealment, blinding, and withdrawals.
Main Results:
- Alendronate (10 mg/day) significantly reduced vertebral fractures in both primary (45% RR reduction) and secondary (45% RR reduction) prevention.
- Significant reductions in nonvertebral (23% RR), hip (53% RR), and wrist (50% RR) fractures were observed for secondary prevention only.
- No statistically significant increase in adverse events was found in RCTs, though observational data suggest risks for upper gastrointestinal injury and osteonecrosis of the jaw.
Conclusions:
- Alendronate at 10 mg/day demonstrates significant benefits for secondary prevention of major osteoporotic fractures.
- Clinically important reductions in vertebral fractures were noted for primary prevention.
- While effective, potential gastrointestinal and jaw-related adverse events warrant consideration.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Osteoclasts in Bone Remodeling
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...